References analysis of the Wikipedia article "Receptor cannabinoide" in the Spanish version

doi.org

dx.doi.org

Aizpurua-Olaizola, Oier; Elezgarai, Izaskun; Rico-Barrio, Irantzu; Zarandona, Iratxe; Etxebarria, Nestor; Usobiaga, Aresatz. «Targeting the endocannabinoid system: future therapeutic strategies». Drug Discovery Today. doi:10.1016/j.drudis.2016.08.005. Consultado el 5 de septiembre de 2016.

Howlett AC (August 2002). «The cannabinoid receptors». Prostaglandins Other Lipid Mediat. 68-69: 619-31. PMID 12432948. doi:10.1016/S0090-6980(02)00060-6.

Mackie K (May 2008). «Cannabinoid receptors: where they are and what they do». J. Neuroendocrinol. 20 Suppl 1: 10-4. PMID 18426493. doi:10.1111/j.1365-2826.2008.01671.x.

Graham ES, Ashton JC, Glass M (2009). «Cannabinoid receptors: a brief history and "what's hot"». Front. Biosci. 14 (14): 944-57. PMID 19273110. doi:10.2741/3288.

Sylvaine G, Sophie M, Marchand J, Dussossoy D, Carriere D, Carayon P, Monsif B, Shire D, LE Fur G, Casellas P (1995). «Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations». Eur J Biochem. 232 (1): 54-61. PMID 7556170. doi:10.1111/j.1432-1033.1995.tb20780.x.

Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990). «Structure of a cannabinoid receptor and functional expression of the cloned cDNA». Nature 346 (6284): 561-4. PMID 2165569. doi:10.1038/346561a0.

Gérard CM, Mollereau C, Vassart G, Parmentier M (1991). «Molecular cloning of a human cannabinoid receptor which is also expressed in testis». Biochem. J. 279 (Pt 1): 129-34. PMC 1151556. PMID 1718258. doi:10.1042/bj2790129.

Pacher P, Mechoulam R (2011). «Is lipid signaling through cannabinoid 2 receptors part of a protective system?». Prog Lipid Res. 50 (2): 193-211. PMC 3062638. PMID 21295074. doi:10.1016/j.plipres.2011.01.001.

Begg M, Pacher P, Bátkai S, Osei-Hyiaman D, Offertáler L, Mo FM, Liu J, Kunos G (2005). «Evidence for novel cannabinoid receptors». Pharmacol. Ther. 106 (2): 133-45. PMID 15866316. doi:10.1016/j.pharmthera.2004.11.005.

Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007). «The orphan receptor GPR55 is a novel cannabinoid receptor». Br. J. Pharmacol. 152 (7): 1092-1101. PMC 2095107. PMID 17876302. doi:10.1038/sj.bjp.0707460.

Latek, D; Kolinski, M; Ghoshdastider, U; Debinski, A; Bombolewski, R; Plazinska, A; Jozwiak, K; Filipek, S (2011). «Modeling of ligand binding to G protein coupled receptors: Cannabinoid CB1, CB2 and adrenergic β 2 AR». Journal of Molecular Modeling 17 (9): 2353-66. PMID 21365223. doi:10.1007/s00894-011-0986-7.

Munro S, Thomas KL, Abu-Shaar M (1993). «Molecular characterization of a peripheral receptor for cannabinoids». Nature 365 (6441): 61-65. PMID 7689702. doi:10.1038/365061a0.

Kyrou I, Valsamakis G, Tsigos C (noviembre de 2006). «The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome». Ann. N. Y. Acad. Sci. 1083: 270-305. PMID 17148745. doi:10.1196/annals.1367.024.

Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Bátkai S, Harvey-White J, Mackie K, Offertáler L, Wang L, Kunos G (2005). «Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity». J. Clin. Invest. 115 (5): 1298-305. PMC 1087161. PMID 15864349. doi:10.1172/JCI23057.

«Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling». Nature Neuroscience 18: 75-86. doi:10.1038/nn.3892.

Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G (November 1999). «Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors». Proc. Natl. Acad. Sci. U.S.A. 96 (24): 14136-41. PMC 24203. PMID 10570211. doi:10.1073/pnas.96.24.14136.

McHugh D, Tanner C, Mechoulam R, Pertwee RG, Ross RA (February 2008). «Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2». Mol. Pharmacol. 73 (2): 441-50. PMID 17965195. doi:10.1124/mol.107.041863.

McHugh D; Hu SS-J; Rimmerman N; Juknat A; Vogel Z; Walker JM; Bradshaw HB (March 2010). «N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor». BMC Neuroscience 11: 44. PMC 2865488. PMID 20346144. doi:10.1186/1471-2202-11-44.

Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, Shabon U, Bao W, Aiyar N, Yue TL, Brown AJ, Morrison AD, Douglas SA (November 2007). «The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects». Br. J. Pharmacol. 152 (5): 825-31. PMC 2190033. PMID 17704827. doi:10.1038/sj.bjp.0707419.

Overton HA, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, Griffin G, Jackson HC, Procter MJ, Rasamison CM, Tang-Christensen M, Widdowson PS, Williams GM, Reynet C (March 2006). «Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents». Cell Metab. 3 (3): 167-75. PMID 16517404. doi:10.1016/j.cmet.2006.02.004.

de Fonseca FR, Schneider M (June 2008). «The endogenous cannabinoid system and drug addiction: 20 years after the discovery of the CB1 receptor». Addict Biol 13 (2): 143-6. PMID 18482429. doi:10.1111/j.1369-1600.2008.00116.x. Archivado desde el original el 18 de julio de 2011.

Brown AJ (November 2007). «Novel cannabinoid receptors». Br. J. Pharmacol. 152 (5): 567-75. PMC 2190013. PMID 17906678. doi:10.1038/sj.bjp.0707481.

Demuth DG, Molleman A (2006). «Cannabinoid signalling». Life Sci. 78 (6): 549-63. PMID 16109430. doi:10.1016/j.lfs.2005.05.055.

Mukhopadhyay P, Bátkai S, Rajesh M, Czifra N, Harvey-White J, Haskó G, Zsengeller Z, Gerard NP, Liaudet L, Kunos G, Pacher P (2007). «Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity». J Am Coll Cardiol. 50 (6): 528-36. PMC 2239316. PMID 17678736. doi:10.1016/j.jacc.2007.03.057.x.

Mukhopadhyay P, Rajesh M, Bátkai S, Patel V, Kashiwaya Y, Liaudet L, Evgenov OV, Mackie K, Haskó G, Pacher P (2010). «CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes». Cardiovasc Res. 85 (4): 773-784. PMC 2819835. PMID 19942623. doi:10.1093/cvr/cvp369.

Han KH, Lim S, Ryu J, Lee CW, Kim Y, Kang JH, Kang SS, Ahn YK, Park CS, Kim JJ (2009). «CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages». Cardiovasc Res. 84 (3): 378-86. PMID 19596672. doi:10.1093/cvr/cvp240.

Sugamura K, Sugiyama S, Nozaki T, Matsuzawa Y, Izumiya Y, Miyata K, Nakayama M, Kaikita K, Obata T, Takeya M, Ogawa H (2009). «Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages». Circulation. 119 (1): 28-36. PMID 19103987. doi:10.1161/CIRCULATIONAHA.108.811992.

Mukhopadhyay P, Horváth B, Rajesh M, Matsumoto S, Saito K, Bátkai S, Patel V, Tanchian G, Gao RY, Cravatt BF, Haskó G, Pacher P (2011). «Fatty acid amide hydrolase is a key regulator of the endocannabinoid-induced myocardial tissue injury». Free Radic Biol Med. 50 (1): 179-195. PMC 3022384. PMID 21070851. doi:10.1016/j.freeradbiomed.2010.11.002.

Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I (January 2006). «Peripheral cannabinoid receptor, CB2, regulates bone mass». Proc. Natl. Acad. Sci. U.S.A. 103 (3): 696-701. PMC 1334629. PMID 16407142. doi:10.1073/pnas.0504187103.

Pacher P, Bátkai S, Kunos G (2006). «The Endocannabinoid System as an Emerging Target of Pharmacotherapy». Pharmacol. Rev. 58 (3): 389-462. PMC 2241751. PMID 16968947. doi:10.1124/pr.58.3.2.

Gaoni Y, Mechoulam R (1964). «Isolation, structure and partial synthesis of an active constituent of hashish». J. Am. Chem. Soc. 86 (8): 1646-1647. doi:10.1021/ja01062a046.

Ashton JC, Wright JL, McPartland JM, Tyndall JD (2008). «Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists». Curr. Med. Chem. 15 (14): 1428-43. PMID 18537620. doi:10.2174/092986708784567716. Archivado desde el original el 21 de marzo de 2017. Consultado el 11 de enero de 2020.

Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, Pertwee RG (February 1999). «Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630». Br. J. Pharmacol. 126 (3): 665-72. PMC 1565857. PMID 10188977. doi:10.1038/sj.bjp.0702351.

Whiteside GT, Lee GP, Valenzano KJ (2007). «The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists». Curr. Med. Chem. 14 (8): 917-36. PMID 17430144. doi:10.2174/092986707780363023.

Steffens S, Veillard NR, Arnaud C, Pelli G, Burger F, Staub C, Karsak M, Zimmer A, Frossard JL, Mach F (2005). «Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice». Nature 434 (7034): 782-6. PMID 15815632. doi:10.1038/nature03389.

Panikashvili D, Simeonidou C, Ben-Shabat S, Hanuš L, Breuer A, Mechoulam R, Shohami E (2001). «An endogenous cannabinoid (2-AG) is neuroprotective after brain injury». Nature 413 (6855): 527-31. PMID 11586361. doi:10.1038/35097089.

Ligresti, A.; Villano, R.; Allarà, M.; Ujváry, I. N.; Di Marzo, V. (2012). «Kavalactones and the endocannabinoid system: The plant-derived yangonin is a novel CB1 receptor ligand». Pharmacological Research 66 (2): 163-169. PMID 22525682. doi:10.1016/j.phrs.2012.04.003.

Frost JM, Dart MJ, Tietje KR, Garrison TR, Grayson GK, Daza AV, El-Kouhen OF, Yao BB, Hsieh GC, Pai M, Zhu CZ, Chandran P, Meyer MD (January 2010). «Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity». J. Med. Chem. 53 (1): 295-315. PMID 19921781. doi:10.1021/jm901214q.

Aung MM, Griffin G, Huffman JW, Wu M, Keel C, Yang B, Showalter VM, Abood ME, Martin BR (August 2000). «Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB₁ and CB₂ receptor binding». Drug Alcohol Depend 60 (2): 133-40. PMID 10940540. doi:10.1016/S0376-8716(99)00152-0.

nih.gov

ncbi.nlm.nih.gov

Howlett AC (August 2002). «The cannabinoid receptors». Prostaglandins Other Lipid Mediat. 68-69: 619-31. PMID 12432948. doi:10.1016/S0090-6980(02)00060-6.

Mackie K (May 2008). «Cannabinoid receptors: where they are and what they do». J. Neuroendocrinol. 20 Suppl 1: 10-4. PMID 18426493. doi:10.1111/j.1365-2826.2008.01671.x.

Graham ES, Ashton JC, Glass M (2009). «Cannabinoid receptors: a brief history and "what's hot"». Front. Biosci. 14 (14): 944-57. PMID 19273110. doi:10.2741/3288.

Munro S, Thomas KL, Abu-Shaar M (1993). «Molecular characterization of a peripheral receptor for cannabinoids». Nature 365 (6441): 61-65. PMID 7689702. doi:10.1038/365061a0.

Brown AJ (November 2007). «Novel cannabinoid receptors». Br. J. Pharmacol. 152 (5): 567-75. PMC 2190013. PMID 17906678. doi:10.1038/sj.bjp.0707481.

Demuth DG, Molleman A (2006). «Cannabinoid signalling». Life Sci. 78 (6): 549-63. PMID 16109430. doi:10.1016/j.lfs.2005.05.055.

Pacher P, Bátkai S, Kunos G (2006). «The Endocannabinoid System as an Emerging Target of Pharmacotherapy». Pharmacol. Rev. 58 (3): 389-462. PMC 2241751. PMID 16968947. doi:10.1124/pr.58.3.2.

Receptor cannabinoide (Spanish Wikipedia)

bentham-direct.org

doi.org

dx.doi.org

nel.edu

nih.gov

ncbi.nlm.nih.gov

sciencedirect.com

sciguru.org

unc.edu

pdsp.med.unc.edu

web.archive.org

zi-mannheim.de